Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-25 @ 2:22 AM
NCT ID: NCT03924934
Eligibility Criteria: Inclusion Criteria: Category 1: Patients who live at home and meet the following criteria: * CDC-defined HRE isolated during a previous hospitalization or outpatient visit * Home origin * First positive HRE culture within 48 hours of admission (in case of hospitalization) Category 2: Hospitalized patients with CDC-defined HRE isolated during hospitalization who are not discharged home and who meet any of the following criteria: * Admitted from other care facility (not home origin) * Do not have first positive HRE culture within 48 hours of admission Category 3: Patients with CDC-defined HRE isolated during a previous hospitalization or outpatient visit who are eventually discharged home and who meet any of the following criteria: * Admitted from other care facility (not home origin) * Do not have first positive HRE culture within 48 hours of admission (in case of hospitalization) Category 4: Participants who meet the following criteria: • Community contact of a participant in Category 1 and/or 3. Exclusion Criteria: In all categories, participants who meet the following criteria will be excluded: • Age \<18 years In category 1, the following are exclusionary: * pre-existing renal failure * pre-existing liver disease * immunocompromised * history of malignancy * pregnancy In addition, in category 1, 3 and 4, who meet the following criteria will be excluded: • Unable to provide informed consent
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 99 Years
Study: NCT03924934
Study Brief:
Protocol Section: NCT03924934